Navigation Links
USAID awards $5 million to CONRAD
Date:11/2/2010

Arlington, VA November 2, 2010 CONRAD, leaders in reproductive health and HIV prevention research, today announced a $5 million award from the US Agency for International Development (USAID). The grant will fund research and development of vaginal rings that are contraceptive and also prevent HIV and STI infections.

USAID provided funding for the CAPRISA 004 trial of tenofovir gel, conducted by the Centre for Programme Research for AIDS in South Africa (CAPRISA), which was the first study to show that a vaginal gel can reduce the risk of HIV and herpes infection in women. CONRAD manufactured and provided the tenofovir gel for the study. Tenofovir gel was found to be 39% effective in reducing a woman's risk of becoming infected with HIV during sex and 51% effective in preventing genital herpes infections in the women participating in the trial. The FDA recently granted Fast Track approval designation for tenofovir gel, pending confirmatory results from the NIH-sponsored Phase IIB study, MTN-003, known as VOICE (Vaginal and Oral Interventions to Control the Epidemic.) CONRAD's pre-clinical and product development team are evaluating products that include combination gels and barrier methods, such as an intravaginal ring impregnated with tenofovir and a contraceptive that is the subject of this grant.

"Thanks to USAID, we have been able to manufacture the first product to reduce women's risk of HIV and herpes," said Henry Gabelnick, Executive Director of CONRAD. "This award will allow us to expedite the evaluation of a dual-protection technology that promises to be a breakthrough in the simultaneous prevention of unplanned pregnancies and HIV infection."

Almost half of all pregnancies worldwide, estimated to be over 100 million annually, are unintended. In sub-Saharan Africa in particular, low contraceptive use rates are reflected by high fertility rates, and thus high infant and maternal mortality rates. This area of the world is also the core of the AIDS epidemic, with 22.4 million people infected with HIV, many of them young women. Poverty, malnutrition, lack of education and gender inequality fuel both unintended pregnancies and HIV transmission; therefore, there is an urgent need to develop dual protection technologies.

"We strongly support research that focuses on women's health in developing countries and a dual-protection product that can prevent unintended pregnancies as well as HIV and other STIs can make an enormous difference," said Dr. Judy Manning with USAID. "CONRAD has been on the forefront of this technology and we are proud to support their work."


'/>"/>

Contact: Annette Larkin
larkinannette@yahoo.com
703-772-6427
CONRAD
Source:Eurekalert

Related biology news :

1. USAID grant awarded to improve food security in Africa
2. USDA awards Virginia Tech $3.8 million to stimulate eastern US wine industry
3. NSF awards new projects for plant genome research
4. Landenberger Foundation awards grant to Scripps Florida scientist to study HIV
5. NSF awards $3.75 million grant to New York Plant Genome Consortium for the creation of BigPlant v1.0
6. NSF awards grants for research on coupled natural and human systems
7. NSF awards grants to study effects of ocean acidification
8. USDA awards grant to GSU professor to study childhood obesity dynamics
9. DFG awards 4 young scientists 2010 Bernd Rendel Prize
10. MARC travel awards announced for the ASBMR 2010 annual meeting
11. Knome Awards Human Exome Sequencing and Analysis to Biomedical Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
Breaking Biology News(10 mins):
(Date:9/20/2017)... Westport, CT (PRWEB) , ... September 20, 2017 , ... ... 2nd annual multi-city Fueling the Growth pitch competition to uncover the top technology-driven, ... Growth will be an integral part of each city’s entrepreneurial events going on that ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... molecular manufacturing and other transformative technologies, announced the winners for the 2017 Foresight ... other for Theory in nanotechnology/molecular manufacturing. , Established in 1993 and named in ...
(Date:9/19/2017)... ... September 19, 2017 , ... VetStem Biopharma ’s CEO and founder, Dr. Bob Harman ... Riordan’s new book "Stem Cell Therapy: A Rising Tide". Dr. Harman and Dr. Riordan ... bonded over an interest in the potential of stem cell therapy and a fast friendship ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... announced a partnership with Cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ in ... analysis to isolate single cells and provide visual documentation of monoclonality for use ...
Breaking Biology Technology: